Status report

Get it in writing

The official USPTO status record for TREVARUM, serial 79109756, as a dated PDF. One price, one document, delivered in about a minute.

INSTANT DELIVERY

Trademark Status Report

$7.99

The USPTO's own status record for this mark, on one dated page.

  • Current status with a plain-English verdict
  • Owner, classes, filing basis, and every key date
  • The mark as it appears on the federal record
  • Every prosecution event, filing to today
  • Source-cited with the exact retrieval date

Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.

Payments launch soon. Leave your email and we'll tell you when this report is available.

Searching stays free, no account, no caps.

Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
TREVARUM
Serial 79109756 · Principal Register
Dead · Cancelled

Owner: Novartis AG
Class 005 - Pharmaceuticals
Filed Jan 13, 2012
Registered Jul 31, 2012

The record shows that TREVARUM is a cancelled Principal Register trademark owned by Novartis AG, a Swiss corporation, and the cancellation was recorded on Jan 13 2022 after the underlying International Registration was deemed dead. The registration covered pharmaceutical preparations for preventing or treating a wide range of diseases—including nervous, immune, cardiovascular, metabolic, respiratory, musculoskeletal, genitourinary, dermatology, oncology, hematology, transplant, ophthalmology and gastro‑intestinal disorders—under International Class 005, so a similar name used for any of those kinds of medicines would present the closest record‑based concern. The record does not give Novartis control over every possible use of the word “TREVARUM” outside that specific pharmaceutical scope. Because the mark was on the Principal Register, there is no Supplemental Register sequence to explain. The prosecution history contains only routine notifications and the final cancellation notice; no oppositions, cancellations or court actions are visible. I'd treat this as a meaningful concern if you plan to brand a drug or related health product with a similar name.

Full event history, owner details, and verdict inside.

The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.

Your name deserves a straight answer.

Search the federal register free. No account, no caps, no waiting around.

Run a free trademark search